Preclinical evaluation improved therapeutic index of SQL70 with intratumoral dosing, implying potential in human trials.
Supplementary Fig S2. SQ3370 increases the therapeutic index when SQL70 is injected intratumorally compared to subcutaneously.
No takes yet. Share an insight, caveat, or question.
Srinivasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: